Age alone is not a contraindication to urgent revascularization for Mortality after cardiogenic shock has including in older adults,589,590 mortality ranging from approximately 40% with milder forms of to >45% with refractory shock.592 of patients in the IABP-SHOCK (Intra-Aortic Balloon Pump in Cardiogenic Shock) II trial presented with NSTEMI,268 of patients in the TRIUMPH (Tilarginine Acetate Injection in a Randomized International Study in Unstable Acute Myocardial Infarction PatientsWith Cardiogenic Shock) trial had ST depres- sion on presentation.592 Of the 23% of patients with ACS who had NSTEMI in the GRACE registry, 4.6% of patients experi- enced cardiogenic shock.593 Of the 2992 patients in shock, 57% underwent cardiac catheterization, and in-hospital revasculariza- tion was performed in 47% of this group. In-hospital mortality of all patients with shock was 59%.594 Patients with NSTEMI developed cardiogenic shock later than patients with STEMI, and had higher-risk clinical character- istics, more extensive CAD, and more recurrent ischemia and infarction before developing shock compared with patients with STEMI, and shock developed later in patients with NSTEMI.151 Patients with NSTEMI constituted >17% of those in the SHOCK They were also older and had more comorbidi- ties but had comparable mortality to patients with STEMI. 